our services

Blake Lapthorn's Biotechnology and Pharmaceuticals group cover advice, assistance and action on all of the following:

licensing and joint ventures

• Licensing structures for bioinformatics products.
• Licensing cell lines and other biotech materials.
• Reach through licensing.
• Collaborative joint ventures and other partnering structures with mid and big pharmas.
• Developments agreements for medical devices.
• Co-marketing agreements.
• Strategic development and manufacturing alliances in diagnostics.

funding issues

• Angel and VC funding rounds
• Initial public offerings
• Debt financing

international issues

• Many biotechnology and pharmaceutical companies, even at the earliest stages of growth, may find themselves dealing with international agreements and intellectual property (IP) issues. The firm is a member of TAGLaw®, a worldwide network of quality law firms selected for their ability to deliver exceptional legal services for all aspects of corporate and commercial work, both contentious and non-contentious. TAGLaw has associated firms in over 80 jurisdictions around the world.

     International services we can provide:

• parallel importations of pharmaceutical products
• advising on the effects of the UK and EU competition law on licenses of worldwide or EMEA rights, even where the entities  involved are not based in the EU

royalties and intellectual property

• Royalty stacking issues
• Patent pooling
• European database rights

combining business and academia

• UK university spin-out companies support advisers who have real experience of helping to accelerate the development of hi-tech businesses. We offer business-orientated advice to enable you to concentrate on commercialising the technology.

For further information please contact Simon Smith in the Biotechnology team on 01865 253284 or at simon.smith@bllaw.co.uk